Recruiting Myelodysplastic Syndromes Studies in New Haven
About Myelodysplastic Syndromes Clinical Trials in New Haven
Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature properly. MDS can progress to acute myeloid leukemia. Treatments include growth factors, chemotherapy, and stem cell transplant.
There are currently 1 myelodysplastic syndromes clinical trials recruiting participants in New Haven, CONNECTICUT. These studies are seeking a combined 90 participants. Research is being sponsored by Akeso. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelodysplastic Syndromes Clinical Trials in New Haven — FAQ
Are there myelodysplastic syndromes clinical trials in New Haven?
Yes, there are 1 myelodysplastic syndromes clinical trials currently recruiting in New Haven, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What myelodysplastic syndromes treatments are being tested?
The 1 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for myelodysplastic syndromes.
Data updated March 2, 2026 from ClinicalTrials.gov